Literature DB >> 21703645

[Clinical and molecular study of five families with resistance to thyroid hormones].

Joaquin Lado Abeal1, Ramón Albero Gamboa, David Araujo Vilar, Olga Barca Mallo, Ignacio Bernabeú Moron, María Teresa Calvo, Isabel Castro Piedras, Jesús Martin Calamata, Fernando Palos Paz, Roberto Peinó, Diego Peteiro, Berta Victoria.   

Abstract

BACKGROUND AND
OBJECTIVE: Resistance to thyroid hormone (RTH) is a syndrome mostly caused by mutations in thyroid hormone receptor beta gen (THRB). We present five families with RTH phenotype. PATIENTS AND METHODS: THRB gene sequencing. In vitro studies to evaluate the mutants response to thyroid hormones and their dominant negative effect. Mechanism of resistance in patients with RTH without THRB mutations quantifying expression of regulator of calcineurin 2 (ZAKI4) and Kruppel-like factor 9 (BTEB) genes in patients fibroblast cultures.
RESULTS: THRB mutations were found in three cases: R243Q, R320C, R429Q. Mutants showed a decreased response to T3. R243Q and R320C had a strong dominant negative effect. One subject without THRB mutation showed changes in ZAKI4 and BTEB expression similar to R320C and the other showed expression levels higher than normal controls.
CONCLUSIONS: Three cases of RTH were caused by THRB heterozygous mutations but in two cases mutations were not found. THRB mutation carriers and one of the patients without mutations share a similar mechanism of resistance and in the other subject RTH is TRβ independent. Copyright Â
© 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21703645     DOI: 10.1016/j.medcli.2010.11.037

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  1 in total

1.  Thyroid hormone resistance and its management.

Authors:  Ana Marcella Rivas; Joaquin Lado-Abeal
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.